Vimarsana
Biggest News Aggregation in the World

Page 17 - Accessed August News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Accessed August. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Accessed August Today - Breaking & Trending Today

Reblozyl Approved to Treat Anemia in ESA-Naive, Lower-Risk MDS - Vimarsana News

Reblozyl Approved to Treat Anemia in ESA-Naive, Lower-Risk MDS

Reblozyl (luspatercept-aamt) is approved as first-line treatment for anemia in adults with very low- to intermediate-risk MDS.

Expensive Treatment Associated With Low Retention Rates Among Patients With Hepatic Encephalopathy - Vimarsana News

Expensive Treatment Associated With Low Retention Rates Among Patients With Hepatic Encephalopathy

Investigators highlighted an association between treatment retention over time and the out-of-pocket cost for patients with hepatic encephalopathy taking rifaximin.

The Unbridled Potential of Electronic Hand Hygiene Monitoring Systems - Vimarsana News

The Unbridled Potential of Electronic Hand Hygiene Monitoring Systems

In the fight against health care-associated infections, EHHCM systems are a key weapon.

European Commission approves Roche's Evrysdi for babies under two months old with spinal muscular atrophy (SMA) - Vimarsana News

European Commission approves Roche's Evrysdi for babies under two months old with spinal muscular atrophy (SMA)

Evrysdi available to treat people of all ages with SMA in the European Union, including babies from birth1Approval is based on interim data from ongoing RAINBOWFISH trial showing majority of...

Novartis presents new long-term Leqvio® (inclisiran) data demonstrating consistent efficacy and safety beyond six years - Vimarsana News

Novartis presents new long-term Leqvio® (inclisiran) data demonstrating consistent efficacy and safety beyond six years

Results from the ORION-8 open-label extension trial show twice-yearly* Leqvio, in addition to statin therapy, provides consistent low-density lipo...